Global Myeloproliferative Disorders Drugs Market is expanding at a significant growth rate due to advancements in targeted therapies, increasing prevalence of myeloproliferative disorders, growing ...
Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen’s leadership believes that ...
"According to the latest BCC Research study, "The global ADCs market is showing a rapid growth trend, with growth rates of 36.5% and 40.7% in 2022 and 2023, respectively, reaching a value of $10.8 ...